Michael Hencke | Head of IR |
Michel Vounatsos | CEO |
Priya Singhal | Interim Head, Research and Development |
Mike McDonnell | CFO |
Matthew Harrison | Morgan Stanley |
Umer Raffat | Evercore |
Robyn Karnauskas | Truist Securities |
Salveen Richter | Goldman Sachs |
Michael Yee | Jefferies |
Cory Kasimov | JPMorgan |
Marc Goodman | SVB |
Brian Abrahams | RBC Capital Markets |
Geoff Meacham | Bank of America Merrill Lynch |
Jay Olson | Oppenheimer |
Philip Nadeau | Cowen & Company |
Mohit Bansal | Wells Fargo |
Good morning. My name is Cecilia and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen First Quarter 2022 Earnings Call and Business Update. All lines have been placed on mute to prevent any background noise [Operator Instructions]. Thank you.